Article

Idenix Names Weidenbruch General Counsel

Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel.

Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel. Before joining Idenix, Weidenbruch served as general counsel at Abraxis BioScience Inc. and in various legal roles at Amgen.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.